J G Bernstein, J Koch-Weser. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Action Potentials/drug effectsAdministration, OralAdultAgedArrhythmias, Cardiac/drug therapyBretylium Compounds/administration & dosageBretylium Compounds/adverse effectsBretylium Compounds/therapeutic useClinical Trials as TopicDrug ResistanceEvaluation Studies as TopicFemaleFollow-Up StudiesHeart Conduction System/drug effectsHeart Ventricles/physiopathologyHumansHypertension/chemically inducedHypotension, Orthostatic/chemically inducedMaleMiddle AgedMovement Disorders/chemically inducedNorepinephrine/metabolismSympathetic Nervous System/drug effectsTachycardia/drug therapyTosyl Compounds/therapeutic useVentricular Fibrillation/drug therapyVomiting/chemically induced
Substances： See more » Bretylium CompoundsTosyl CompoundsNorepinephrine
Year: 1972 PMID： 4553611 DOI： 10.1161/01.cir.45.5.1024
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690